A new iData report examines the orthopedic external fixation trauma device market.
Here are eight key trends:
1. The orthopedic external fixation trauma device market is driven by market growth in the hip external fixation market. The growth there is due to increased hip fracture in the aging population in the United States and advancements in infection prevention technologies.
2. Hip fractures account for the largest total number of bone fixation procedures in the Untied States, and most are associated with accidents and falls.
3. The average selling price of the hip external fixation devices are expected to continue increasing across the board.
4. However, price increases will then settle down as more competitors enter the market, forcing manufacturers to be competitive in their pricing.
5. The external fixator market growth is limited by increasing propensity for using internal fixation devices, like plates and screws or intramedullary nails. The patient outcomes in some applications are better with internal fixation and there is increased visibility during fracture surgery.
6. External fixation is still preferable in some indications when invasive surgery is contraindicated and with some multiple traumas.
7. External fixation benefits include decreased or eliminated blood loss, decreased operating times, early return-to-motion and lower levels of soft tissue disturbance.
8. DePuy Synthes has the lead position in the United States external fixation market with around 40 percent of the market share. Other competitors include Stryker, Smith & Nephew, Orthofix, Zimmer, Acumed, DJO Surgical, Nutek Orthopaedics and Vilex.